RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Gertraud Maskarinec to Hydroxyestrones

This is a "connection" page, showing publications Gertraud Maskarinec has written about Hydroxyestrones.
Connection Strength

0.671
  1. Maskarinec G, Heak S, Morimoto Y, Custer L, Franke AA. The relation of urinary estrogen metabolites with mammographic densities in premenopausal women. Cancer Epidemiol. 2012 Oct; 36(5):e310-6.
    View in: PubMed
    Score: 0.423
  2. Maskarinec G, Morimoto Y, Heak S, Isaki M, Steinbrecher A, Custer L, Franke AA. Urinary estrogen metabolites in two soy trials with premenopausal women. Eur J Clin Nutr. 2012 Sep; 66(9):1044-9.
    View in: PubMed
    Score: 0.107
  3. Morimoto Y, Conroy SM, Pagano IS, Isaki M, Franke AA, Nordt FJ, Maskarinec G. Urinary estrogen metabolites during a randomized soy trial. Nutr Cancer. 2012; 64(2):307-14.
    View in: PubMed
    Score: 0.104
  4. Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA. A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. 2017 Aug; 165(1):97-107.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support